These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17141878)

  • 1. Orexin and psychiatric symptoms in suicide attempters.
    Brundin L; Petersén A; Björkqvist M; Träskman-Bendz L
    J Affect Disord; 2007 Jun; 100(1-3):259-63. PubMed ID: 17141878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt.
    Brundin L; Björkqvist M; Träskman-Bendz L; Petersén A
    J Affect Disord; 2009 Feb; 113(1-2):179-82. PubMed ID: 18533274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transthyretin in cerebrospinal fluid from suicide attempters.
    Schultz K; Träskman-Bendz L; Petersén A
    J Affect Disord; 2008 Jul; 109(1-2):205-8. PubMed ID: 18166229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder.
    Brundin L; Björkqvist M; Petersén A; Träskman-Bendz L
    Eur Neuropsychopharmacol; 2007 Sep; 17(9):573-9. PubMed ID: 17346943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine and amphetamine regulated transcript (CART) in suicide attempters.
    Brundin L; Björkqvist M; Träskman-Bendz L; Petersén A
    Psychiatry Res; 2008 Mar; 158(2):117-22. PubMed ID: 18096245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH).
    Dohi K; Ripley B; Fujiki N; Ohtaki H; Yamamoto T; Goto Y; Nakamachi T; Shioda S; Aruga T; Nishino S
    Regul Pept; 2008 Jan; 145(1-3):60-4. PubMed ID: 17868933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
    Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid-orexin levels and sleep attacks in four patients with Parkinson's disease.
    Asai H; Hirano M; Furiya Y; Udaka F; Morikawa M; Kanbayashi T; Shimizu T; Ueno S
    Clin Neurol Neurosurg; 2009 May; 111(4):341-4. PubMed ID: 19097685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid.
    Sarchielli P; Rainero I; Coppola F; Rossi C; Mancini M; Pinessi L; Calabresi P
    Cephalalgia; 2008 Jul; 28(7):714-22. PubMed ID: 18479471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF biomarkers in suicide attempters--a principal component analysis.
    Lindqvist D; Janelidze S; Erhardt S; Träskman-Bendz L; Engström G; Brundin L
    Acta Psychiatr Scand; 2011 Jul; 124(1):52-61. PubMed ID: 21198458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disentangling dysthymia from major depressive disorder in suicide attempters' suicidality, comorbidity and symptomatology.
    Holmstrand C; Engström G; Träskman-Bendz L
    Nord J Psychiatry; 2008; 62(1):25-31. PubMed ID: 18389422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suicidal intent and psychiatric symptoms among inpatient suicide attempters.
    Lindqvist D; Nimeus A; Träskman-Bendz L
    Nord J Psychiatry; 2007; 61(1):27-32. PubMed ID: 17365786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF 5-HIAA and DST non-suppression -independent biomarkers in suicide attempters?
    Jokinen J; Mårtensson B; Nordström AL; Nordström P
    J Affect Disord; 2008 Jan; 105(1-3):241-5. PubMed ID: 17499856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF 5-HIAA, suicide intent and hopelessness in the prediction of early suicide in male high-risk suicide attempters.
    Samuelsson M; Jokinen J; Nordström AL; Nordström P
    Acta Psychiatr Scand; 2006 Jan; 113(1):44-7. PubMed ID: 16390368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF orexin A concentrations and expressions of the orexin-1 receptor in rat hippocampus after cardiac arrest.
    Dohi K; Nishino S; Nakamachi T; Ohtaki H; Morikawa K; Takeda T; Shioda S; Aruga T
    Neuropeptides; 2006 Aug; 40(4):245-50. PubMed ID: 16930690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
    Taiwo OB; Russell IJ; Mignot E; Lin L; Michalek JE; Haynes W; Xiao Y; Zeitzer JM; Larson AA
    Sleep Med; 2007 Apr; 8(3):260-5. PubMed ID: 17369087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased cerebrospinal fluid hypocretin-1 (orexin A) in patients after repetitive generalized tonic-clonic seizures.
    Rejdak K; Papuć E; Grieb P; Stelmasiak Z
    Epilepsia; 2009 Jun; 50(6):1641-4. PubMed ID: 19175390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid orexin in aneurysmal subarachnoid haemorrhage - a pilot study.
    Ang BT; Tan WL; Lim J; Ng I
    J Clin Neurosci; 2005 Sep; 12(7):758-62. PubMed ID: 16150596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPT axis, CSF monoamine metabolites, suicide intent and depression severity in male suicide attempters.
    Jokinen J; Samuelsson M; Nordström AL; Nordström P
    J Affect Disord; 2008 Nov; 111(1):119-24. PubMed ID: 18342374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH).
    Dohi K; Ripley B; Fujiki N; Ohtaki H; Shioda S; Aruga T; Nishino S
    Peptides; 2005 Nov; 26(11):2339-43. PubMed ID: 15893406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.